The move marks the first time the FDA has formally forced the removal of a drug
The London-based company aims to help combat late-stage cancers using proprietary technology
Around 300 women in England with HER2-negative early breast cancer will be eligible for the new drug each year
By Lorin Gu, founding partner at Recharge Capital
The new period shorts will debut on the pitch during the Women's World Cup 2023
The at-home technology aims to address key women's health areas, including fertility, contraception and endocrine conditions
Elvie is one of the first beneficiaries of HSBC UK’s new £250m growth lending proposition
Research reveals a complex and overlapping system that contributes to inequalities in treatment experience
The treatment could "transform" the life of women suffering from menopause symptoms globally, say experts
The singer wants to champion the brand's mission to create an open dialogue around sexual wellness
